TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed April 22, 1977
TCL Archive Cancer Epidemiology Hampered By Bureaucratic Delays, Lack of Cooperation, NCI Group Says September 29, 1978
TCL Archive Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval August 31, 2012
TCL Archive Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC September 3, 1999
